4//SEC Filing
Vasquez Nicki 4
Accession 0001209191-23-042244
CIK 0001382101other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 6:40 PM ET
Size
9.1 KB
Accession
0001209191-23-042244
Insider Transaction Report
Form 4
Vasquez Nicki
Chief Port. Strat & Alnce Ofcr
Transactions
- Exercise/Conversion
Common Stock
2023-07-12+3,250→ 26,111 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2023-07-12−3,250→ 6,500 totalExp: 2025-07-12→ Common Stock (3,250 underlying) - Tax Payment
Common Stock
2023-07-12$4.70/sh−1,123$5,278→ 24,988 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on July 12, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001877585
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 6:40 PM ET
- Size
- 9.1 KB